Clinical Trials Browser

Phase 1 × Waldenstrom Macroglobulinemia × Rifaximin × Clear all

NCT03820817 2025-04-20

Rifaximin in Patients With Monoclonal Gammopathy

Phase 1 Active not recruiting

Waldenstrom Macroglobulinemia, Paraproteinemias